The 2023 PQA Annual Meeting poster session will feature 25 quality improvement and research projects. Sponsored by Pharmacy Quality Solutions, the session provides an opportunity for authors to showcase their work and for attendees to engage in insightful dialogue about health care quality.
PQA will bring its members and industry experts together on November 2 to discuss the state of medication therapy management (MTM) practice, implications of recent Centers for Medicare & Medicaid Services proposals and opportunities to evolve MTM quality measurement.
Shadowing programs are a great way to gain knowledge and insights about technical programs and processes.
The Pharmacy Quality Alliance (PQA) is providing scholarships for minority health care professional students to attend the 2023 PQA Annual Meeting, May 10-12, in Nashville, Tenn., and participate in the pre-meeting Medication Use Quality (MUQ) Live workshop on May 10. This scholarship opportunity is part of the PQA Diverse Quality Leaders Program.
In the year ahead, PQA will continue developing innovative measure approaches for high-impact areas of care. From technical expert panels, stakeholder advisory meetings, the measure endorsement vote and convening events focused on future measure opportunities, PQA members have the opportunity to be involved each step of the way!
PQA’s education team has a lot on deck for 2023, focused on the latest in best practices and innovative approaches to improve quality medication use. PQA started the year by publishing the second edition of the PQA Social Determinants of Health (SDOH) Resource Guide and will continue education offerings through quality forum webinars, highlighting PQA members during the 2023 PQA Annual Meeting and the much-anticipated relaunch of the PQA Medication Use Quality certificate program.
PQA’s 2023 calendar is full of opportunities to engage in our work and advance the quality of medication use. PQA meetings and convening events are just one example of how members can engage with the wide array of health care stakeholders from across our membership.
It’s a new year and there are several big things on the horizon to keep an eye on in pharmacy, medication use and high-quality, value-based care.
PQA’s 2023 calendar is shaping up to be full of opportunities for members to engage in our work and advance the quality of medication use. PQA is building on the momentum we gained in 2022, and there will be many opportunities to engage in our:
PQA has published nearly 90 blogs this year, providing insights and updates on our work to improve medication use quality. As we close out 2022, here’s a look back at the top five blogs of the year.
PQA is dedicated to improving safe, effective and appropriate medication use and addressing issues that impact a person’s ability to access and use medications. Many of those issues are driven by inequities in our society and health care system.
There are several important policy issues that could impact pharmacists’ ability to positively affect the quality of care for patients through the use of pharmacy performance measures.
What constitutes quality and value in medication use?
PQA, the Pharmacy Quality Alliance, is launching a national initiative to prioritize research and measurement strategies to improve the quality of care for individuals using oral anticancer medications (OAM).
Social determinants of health (SDOH) are a priority for PQA because, in addition to traditional care, issues like medication cost, literacy, transportation and food security impact a person’s ability to access medications and use them safely and effectively.
The 2022 PQA Annual Meeting hosted a general session to discuss recent changes across Centers for Medicare & Medicaid (CMS) quality programs and future implications.
RAND convened a technical expert panel (TEP) in February 2022 to gather input about potentially developing a measure to capture value-based care arrangements (VBAs) that Medicare Advantage (MA) organizations have with contracted providers. The Centers for Medicare and Medicaid (CMS) could consider including such a measure in future MA and Part D Star Ratings.
As the summer winds down, we are quickly approaching the end of 2022. PQA has been busy this year, in collaboration with our members, advancing the quality of medication use through measure development and stewardship, education, research and convening.
The 2022 PQA Annual Meeting poster session featured 24 quality improvement and research projects. Sponsored by Pharmacy Quality Solutions, the session provided an opportunity for authors to showcase their work and for attendees to engage in insightful dialogue about health care quality.
Medication adherence quality measures are relevant and high-impact, according to PQA’s Ben Shirley, Melissa Castora-Binkley and Lisa Hines, whose Population Health Management point of view article was published online April 29.
They explain that adherence measures in the Centers for Medicare & Medicaid Services (CMS) Part D Star Ratings have contributed to immense public health benefits and savings over the last decade. As the measures evolve to integrate new data sources and address equity, their value to the health system will continue. They are an excellent example of how evidence-based quality measures implemented into accountability programs with meaningful incentives can move the needle and improve population health.
